| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUACCACAGCCUUCAUCUGCGCCCUGGGGCCAGGACUGCUGCUGUCACU… | 3082 nt | 0.6317 | |
| AUACCACAGCCUUCAUCUGCGCCCUGGGGCCAGGACUGCUGCUGUCACU… | 2946 nt | 0.6273 | |
| GUGUAAAGCUGCCUAGGCUCCCAGUAAGCAUGAUGGGAGCAUCUGCAGU… | 2769 nt | 0.6074 | |
| AUACCACAGCCUUCAUCUGCGCCCUGGGGCCAGGACUGCUGCUGUCACU… | 1634 nt | 0.6242 |
This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
A study in humans demonstrated that the ENG is a highly expressed stromal cell surface marker in menstrual blood-derived stem cells (MenSCs) across all donor age groups and at different passage numbers, with its immunophenotype remaining stable despite aging or long-term culture [Chen et al. DOI:PMC4713568]. In rats, research on adipose-derived stem cells (ASCs) following severe burn injury showed that protein and mRNA levels of the ENG in ASCs were not significantly altered by the injury, confirming its stable expression as a positive identification marker for these cells [Prasai et al. DOI:10.007/s12015-017-9721-9].